FI79104B - Foerfarande foer framstaellning av ett nytt terapeutiskt anvaendbart dihydropyridinderivat. - Google Patents
Foerfarande foer framstaellning av ett nytt terapeutiskt anvaendbart dihydropyridinderivat. Download PDFInfo
- Publication number
- FI79104B FI79104B FI834692A FI834692A FI79104B FI 79104 B FI79104 B FI 79104B FI 834692 A FI834692 A FI 834692A FI 834692 A FI834692 A FI 834692A FI 79104 B FI79104 B FI 79104B
- Authority
- FI
- Finland
- Prior art keywords
- product
- formula
- alkyl
- methyl
- substituent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C47/00—Compounds having —CHO groups
- C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
- C07C47/55—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Saccharide Compounds (AREA)
- Indole Compounds (AREA)
Claims (7)
1. Förfarande för framställning av ett nytt, terapeutiskt användbart dihydropyridinderivat med formeln I
5 HR r1ooc Λχ coor2 i iT '•''\CH--0-Y-NHR3
3 H 10 där R är en fenylgrupp med eventuellt en eller tvä substi-tuenter vllka är oberoende av varandra nitro, halogen, -C4-alkyl, C:-C4-alkoxi, hydroxi, trifluormetyl eller cya-no;
15 R1 och R2 är vardera oberoende av varandra C1-C4-alkyl eller 2-metoxletyl; Y är -(CH2 )2 -; R3 är bunden tili den närliggande kväveatomen medelst en kolatom och R3 är antingen (a) en monocyklisk 5- eller 6-20 ledad heterocyklisk grupp med ätminstone en kväveatom som heteroatom och dessutom eventuellt en eller tvä andra he-teroatomer eller grupper, vilka är oberoende av varandra 0, S, (S^O), N eller (N-»0) med eventuellt C:-C4 -alkyl, Cx-C4-alkoxi, halogen, hydroxi, oxo, cyano, 3-i^-^-al-25 kyl)ureido, fenyl, fenoxi, pyridyl, acetyl, (C^-C^-alko-xi)-karbonyl, -NR4 R5 , -S02NR4R5 eller -CONR4R5 som substi-tuenter, varvid antingen R4 och R5 är vardera oberoende av varandra väte eller C4 -C4 -alkyl eller R4 och R5 beteck-nar tillsammans med den kväveatom tili vilken de är bundna 30 en mättad 5- eller 6-ledad heterocyklisk grupp, vilken eventuellt innehäller en annan heteroatom eller grupp vilken är 0, S’, NH, N(C1-C4-alkyl) eller NCHO, eller (b) en bicyklisk grupp, vilken är definierad i punkt (a), en eventuellt substituerad 5- eller 6-ledad heterocyklisk 35 grupp, vilken är fusionerad med en imidazol- eller bensen- 95 791 04 ring, vilken bensenring eventuellt är substituerad med Cx -C4-alkyl, C1-C4-alkoxi eller halogen; eller ett farmaseu-tiskt godtagbart salt därav, kännetecknat d ä r a v, 5 att en förening med formeln II
1. R 2 R OOC COOR Ti^ (II>
10 CH3^ N ' CH2OYNH2 H där R, R1 , R2 och Y är som ovan definierats, omsätts med 15 en förening med formeln R3 .Q där R3 är som ovan definierats och Q en avgäende grupp, varefter eventuellt ett eller flera av följande steg föl-jer: 20 (a) omvandlande av en produkt med formeln (I), vari R3 innehäller en (Cx-C4-alkoxi)karbonylsubstituent, till en produkt, väri R3 innehäller en N-(CX-C4-alkyl)karbamo-ylsubstituent, genom reaktion med en Cx-C4-alkylamin; (b) omvandlande av en produkt med formeln (I), vari 25 R3 innehäller en metoxisubstituent, till en produkt, vari R3 innehäller en aminosubstituent, genom reaktion med am-moniak; (c) omvandlande av en produkt med formeln (I), vari R3 innehäller en aminosubstituent, till en produkt, vari
30 R3 innehäller en -NHC0NH(Cx-C4-alkyl)-substituent, genom reaktion med ett Cx-C4-alkylisocyanat; (d) omvandlande av en produkt med formeln (I), vari R3 innehäller en klor- eller bromsubstituent, till en produkt, vari R3 innehäller en substituent med formeln 35 -NR4R5, genom reaktion med en amin med formeln R4 R5 NH,
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8236347 | 1982-12-21 | ||
| GB8236347 | 1982-12-21 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI834692A0 FI834692A0 (fi) | 1983-12-20 |
| FI834692A FI834692A (fi) | 1984-06-22 |
| FI79104B true FI79104B (fi) | 1989-07-31 |
| FI79104C FI79104C (sv) | 1989-11-10 |
Family
ID=10535140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI834692A FI79104C (sv) | 1982-12-21 | 1983-12-20 | Förfarande för framställning av ett nytt terapeutiskt användbart dihyd ropyridinderivat. |
Country Status (24)
| Country | Link |
|---|---|
| US (3) | US4572908A (sv) |
| EP (1) | EP0116769B1 (sv) |
| JP (1) | JPS59118782A (sv) |
| KR (1) | KR860001921B1 (sv) |
| AT (1) | ATE26114T1 (sv) |
| AU (1) | AU546057B2 (sv) |
| CA (1) | CA1215050A (sv) |
| CS (1) | CS249516B2 (sv) |
| DD (1) | DD213920A5 (sv) |
| DE (1) | DE3370481D1 (sv) |
| DK (1) | DK586583A (sv) |
| ES (2) | ES528157A0 (sv) |
| FI (1) | FI79104C (sv) |
| GR (1) | GR81351B (sv) |
| HU (1) | HU193275B (sv) |
| IL (1) | IL70477A (sv) |
| NO (1) | NO159272C (sv) |
| NZ (1) | NZ206614A (sv) |
| PH (1) | PH20114A (sv) |
| PL (2) | PL140573B1 (sv) |
| PT (1) | PT77842B (sv) |
| SU (2) | SU1296006A3 (sv) |
| YU (2) | YU246883A (sv) |
| ZA (1) | ZA839381B (sv) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0125803A3 (en) * | 1983-04-27 | 1987-01-21 | FISONS plc | Pharmaceutically active dihydropyridines |
| GB8331120D0 (en) * | 1983-11-22 | 1983-12-29 | Pfizer Ltd | Benzaldehyde derivatives |
| DE3567460D1 (en) * | 1984-06-07 | 1989-02-16 | Pfizer Ltd | Dihydropyridines |
| GR851819B (sv) * | 1984-08-17 | 1985-11-26 | Wyeth John & Brother Ltd | |
| GB8601382D0 (en) * | 1986-01-21 | 1986-02-26 | Pfizer Ltd | Dihydropyridine antiischaemic & antihypertensive agents |
| US5202330A (en) * | 1985-06-03 | 1993-04-13 | E. R. Squibb & Sons, Inc. | 2-thio or oxo-4-aryl or heterocyclo-1,5(2H)-pyrimidinedicarboxylic acid diesters and 3-acyl-5-pyrimidinecarboxylic acids and esters |
| IT1204421B (it) * | 1986-06-27 | 1989-03-01 | Boehringer Biochemia Srl | 2-(aminoalchiltio)metil-1,4-diidropiridine,un metodo per la loro preparazione e composizioni farmaceutiche che le contengono |
| DE3531498A1 (de) * | 1985-09-04 | 1987-03-05 | Bayer Ag | Dihydropyridin-2-hydroxyamine, verfahren zur herstellung und ihre verwendung in arzneimitteln |
| US4820842A (en) * | 1986-11-19 | 1989-04-11 | Warner-Lambert Company | 2-substituted-1,4-dihydropyridines |
| IT1204948B (it) * | 1987-03-13 | 1989-03-10 | Boheringer Biochemia Robin S P | 2-tiometil-sostituite-piridine, metodo per la loro preparazione e composizioni farmaceutiche che le contengono. |
| US4753946A (en) * | 1987-04-08 | 1988-06-28 | E. R. Squibb & Sons, Inc. | Pyrimidinecarboxylic acid derivatives |
| GB9319341D0 (en) * | 1993-09-17 | 1993-11-03 | Wellcome Found | Novel process |
| GB9611046D0 (en) * | 1996-05-25 | 1996-07-31 | Wivenhoe Techn Ltd | Pharmacological compounds |
| ES2151850B1 (es) * | 1998-10-26 | 2001-08-16 | Esteve Quimica Sa | Intermedio para la sintesis de amlodipino para su obtencion y utilizacion correspondiente. |
| AU2001294354A1 (en) | 2000-12-29 | 2002-07-16 | Bioorganics B.V. | Process for making amlodipine, derivatives thereof, and precursors therefor |
| CA2433193C (en) * | 2000-12-29 | 2006-01-31 | Pfizer Limited | Amide derivative of amlodipine |
| US6653481B2 (en) * | 2000-12-29 | 2003-11-25 | Synthon Bv | Process for making amlodipine |
| CA2501534A1 (en) * | 2002-10-07 | 2004-04-22 | Artesian Therapeutics, Inc. | Dihydropyridine compounds having simultaneous ability to block l-type calcium channels and to inhibit phosphodiesterase type 3 activity |
| EP1975167A1 (en) * | 2007-03-30 | 2008-10-01 | Esteve Quimica, S.A. | Acetone solvate of phthaloyl amlodipine |
| JP2010100562A (ja) * | 2008-10-23 | 2010-05-06 | Daito Kk | アムロジピン製造中間体の精製方法 |
| CN102464608B (zh) * | 2010-11-15 | 2016-05-11 | 江苏先声药物研究有限公司 | 化合物及其作为l-型钙通道阻滞剂或/和乙酰胆碱酯酶抑制剂的应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4284634A (en) * | 1975-07-02 | 1981-08-18 | Fujisawa Pharmaceutical Co., Ltd. | 1,4-Dihydropyridine derivatives, and pharmaceutical method of the same |
| DE2658183A1 (de) * | 1976-12-22 | 1978-07-06 | Bayer Ag | In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| US4177278A (en) * | 1977-04-05 | 1979-12-04 | Bayer Aktiengesellschaft | 2-Alkyleneaminodihydropyridines compounds, their production and their medicinal use |
| DE2740080A1 (de) * | 1977-09-06 | 1979-03-15 | Bayer Ag | 2-alkylenaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| US4144343A (en) * | 1978-01-04 | 1979-03-13 | Merck & Co., Inc. | Heterocycle substituted (3-loweralkylamino-2-R1 O-propoxy)pyridines |
| JPS5547656A (en) * | 1978-09-29 | 1980-04-04 | Dainippon Pharmaceut Co Ltd | 2-(2-substituted aminoethyl)-1,4-dihydropyridine derivative and its derivative |
| DE2844595A1 (de) * | 1978-10-13 | 1980-04-30 | Bayer Ag | Acylaminodihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| SE7910521L (sv) * | 1979-12-20 | 1981-06-21 | Haessle Ab | Nya 2-metyl-6-substituerade-4-(2,3-disubstituerad fenyl)-1,4-dihydropyridin-3,5-diestrar med hypotesiva egenskaper, samt forfarande for deras framstellning, och farmaceutiska beredningar innehallande desamma |
| DE3022030A1 (de) * | 1980-06-12 | 1981-12-17 | Bayer Ag, 5090 Leverkusen | 4-thiazol- bzw. 4-imidazol-substituierte, 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel |
| CS228917B2 (en) * | 1981-03-14 | 1984-05-14 | Pfizer | Method of preparing substituted derivatives of 1,4-dihydropyridine |
| DK161312C (da) * | 1982-03-11 | 1991-12-09 | Pfizer | Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden |
| EP0100189B1 (en) * | 1982-07-22 | 1986-05-28 | Pfizer Limited | Dihydropyridine anti-ischaemic and antihypertensive agents |
| EP0107293A3 (en) * | 1982-09-04 | 1984-06-06 | Pfizer Limited | Dihydropyridines |
| US4515799A (en) * | 1983-02-02 | 1985-05-07 | Pfizer Inc. | Dihydropyridine anti-ischaemic and antihypertensive agents |
-
1983
- 1983-12-16 PL PL1983250215A patent/PL140573B1/pl unknown
- 1983-12-16 PT PT77842A patent/PT77842B/pt not_active IP Right Cessation
- 1983-12-16 PL PL1983245158A patent/PL140069B1/pl unknown
- 1983-12-16 US US06/562,482 patent/US4572908A/en not_active Expired - Lifetime
- 1983-12-19 PH PH30000A patent/PH20114A/en unknown
- 1983-12-19 KR KR1019830006010A patent/KR860001921B1/ko active
- 1983-12-19 ES ES528157A patent/ES528157A0/es active Granted
- 1983-12-19 DE DE8383307719T patent/DE3370481D1/de not_active Expired
- 1983-12-19 AT AT83307719T patent/ATE26114T1/de not_active IP Right Cessation
- 1983-12-19 IL IL70477A patent/IL70477A/xx not_active IP Right Cessation
- 1983-12-19 NZ NZ206614A patent/NZ206614A/en unknown
- 1983-12-19 EP EP83307719A patent/EP0116769B1/en not_active Expired
- 1983-12-19 ZA ZA839381A patent/ZA839381B/xx unknown
- 1983-12-19 NO NO834689A patent/NO159272C/no unknown
- 1983-12-20 FI FI834692A patent/FI79104C/sv not_active IP Right Cessation
- 1983-12-20 CS CS839668A patent/CS249516B2/cs unknown
- 1983-12-20 CA CA000443770A patent/CA1215050A/en not_active Expired
- 1983-12-20 DK DK586583A patent/DK586583A/da not_active Application Discontinuation
- 1983-12-20 AU AU22559/83A patent/AU546057B2/en not_active Ceased
- 1983-12-20 GR GR73290A patent/GR81351B/el unknown
- 1983-12-20 SU SU833682597A patent/SU1296006A3/ru active
- 1983-12-20 YU YU02468/83A patent/YU246883A/xx unknown
- 1983-12-20 DD DD83258248A patent/DD213920A5/de unknown
- 1983-12-20 HU HU834351A patent/HU193275B/hu not_active IP Right Cessation
- 1983-12-21 JP JP58241806A patent/JPS59118782A/ja active Granted
-
1984
- 1984-05-08 SU SU843739756A patent/SU1391499A3/ru active
- 1984-07-30 ES ES534723A patent/ES534723A0/es active Granted
-
1985
- 1985-11-11 YU YU01755/85A patent/YU175585A/xx unknown
-
1986
- 1986-02-14 US US06/830,384 patent/US4670449A/en not_active Expired - Lifetime
- 1986-02-14 US US06/830,292 patent/US4661485A/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI79104B (fi) | Foerfarande foer framstaellning av ett nytt terapeutiskt anvaendbart dihydropyridinderivat. | |
| CA2161542C (en) | Novel 5-pyrrolyl-2-pyridylmethylsulfinyl benzimidazole derivatives | |
| JP7579253B2 (ja) | 甲状腺ホルモン受容体ベータアゴニスト化合物 | |
| FI79103B (fi) | Foerfarande foer framstaellning av terapeutiskt aktiva 1,4-dihydropyridinderivat. | |
| US20040157861A1 (en) | Compositions and methods for inhibiting TGF-beta | |
| PL136217B1 (en) | Method of obtaining novel derivatives of 4-amino-6,7-dimetoxy-2-piprazinoquinazoline | |
| KR100224135B1 (ko) | 퀴놀린 또는 퀴나졸린 유도체, 그 제조 및 용도 | |
| JPS6157587A (ja) | 縮合複素環誘導体および抗潰瘍剤 | |
| CZ9797A3 (en) | Triazole derivative, process of its preparation and pharmaceutical composition containing thereof | |
| EP0132375B1 (en) | Dihydropyridine anti-ischaemic and antihypertensive agents | |
| IE55904B1 (en) | Dihydropyridines | |
| PL167222B1 (pl) | Sposób wytwarzania nowych pochodnych benzimidazolu PL PL PL PL | |
| CA1271751A (en) | Dihydroimidazo[1,2-a]pyrimidine derivatives | |
| HU197576B (en) | Process for production of new 2-tiazolil-imidazo /1,2-a/ piramidines and medical compositions containing these substances | |
| IL94592A (en) | History Transformed by piperidinoalkyl of 1,2,4-triazolone and 1,3,5-triazinedione in compressed bicycles, their preparation and pharmaceutical preparations containing or | |
| JP2646995B2 (ja) | キノリンまたはキナゾリン誘導体およびそれらを含んでなる医薬 | |
| US4460585A (en) | 1-Aryl-4-hydrazinyl-s-triazin-2-ones | |
| CZ357190A3 (en) | Dihydropyrimidothiazine derivatives, process of their preparation and pharmaceutical compositions containing thereof | |
| USRE33125E (en) | 3- and 5-[3-(1-arylureido)]-1,2,4-triazoles | |
| Jyoti et al. | Review on Thiazolo-Triazole as a Promising Anticancer agent | |
| WO1997000875A1 (en) | Benzimidazole derivatives containing fused pyridine | |
| JPH05331149A (ja) | フェノール誘導体 | |
| JP2025020206A (ja) | 甲状腺ホルモン受容体ベータアゴニスト化合物 | |
| JP2564162B2 (ja) | ベンズイミダゾール誘導体の四級塩 | |
| FI100801B (sv) | Förfarande för framställning av nya terapeutiskt användbara 5-substitu erat-tia-cykloalka-£d|-1,2,4-triazolo£1,5-a|pyrimidinderivat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: PFIZER CORPORATION |